Skip to main content
Sam-A Pharm. Co. Ltd logo

Sam-A Pharm. Co. Ltd — Investor Relations & Filings

Ticker · 009300 ISIN · KR7009300005 KO Manufacturing
Open in API
Filings indexed 105 across all filing types
Latest filing 2022-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 009300

About Sam-A Pharm. Co. Ltd

https://www.samapharm.co.kr/eng/main201…

Sam-A Pharm. Co. Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a range of pharmaceutical products. The company specializes in several therapeutic areas, with a primary focus on treatments for respiratory and dermatological conditions. Its portfolio also includes antipyretic, analgesic, and anti-inflammatory medications. Founded in 1945, Sam-A Pharm. operates manufacturing facilities that adhere to high-quality production standards, equivalent to EU-GMP, reflecting its long-standing commitment to improving health and quality of life.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Sam-A Pharmaceutical Co., Ltd. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. It is not a full 10-K (which is a US-specific regulatory filing), but rather a standalone audit report of financial statements, which fits the 'AR' category. FY 2021
2022-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Sam-A Pharmaceutical. It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor (Samil PwC). While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings (DART), this specific format is a standard disclosure announcement of the audit report's submission, which falls under the 'Audit Report / Information' category as it provides the core audit findings and financial summary. FY 2021
2022-03-16 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed with the regulatory body (KRX) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date' (a date when many companies hold their meetings). It explains the operational reasons for this scheduling choice. As it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2022-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Sam-A Pharmaceutical. It contains the agenda for the 49th Annual General Meeting, including items such as the approval of financial statements, election of directors, and remuneration limits. It also includes management's business report and preliminary financial statements. This type of document is a standard proxy statement/notice of meeting sent to shareholders to solicit votes and provide information for the upcoming AGM, which falls under the Proxy Solicitation & Information Statement category.
2022-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Sam-A Pharmaceutical. It outlines the date, location, and agenda items for the upcoming meeting, including the approval of financial statements, dividend declarations, and the election of directors. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2022-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the decision to pay cash dividends, including details such as the dividend amount per share, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2022-02-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.